FindTrial
Sign In

Transdermal Lidocaine for Pain Control During Hysterosalpingography

Transdermal Lidocaine for Pain Control During Hysterosalpingography: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04518189
Enrollment
120
Registered
2020-08-19
Start date
2020-09-01
Completion date
2021-08-31
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Brief summary

the study aims to investigate the effectiveness of Transdermal lidocaine patch for Pain Control During Hysterosalpingography

Detailed description

hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye

Interventions

DRUGlidocaine patch

lidocaine patch applied 3 hours before the procedure

DRUGSham patch

Sham patch applied 3 hours before the procedure

Sponsors

Aswan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

double blind randomized trial

Intervention model description

double blind randomized trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* any patient came for Hysterosalpingography

Exclusion criteria

* any patient has contraindication to Hysterosalpingography

Design outcomes

Primary

MeasureTime frameDescription
Mean pain score during the procedure10 minutesAssessment of pain using visual analog scale 0-10, 0 = minimum and 10 = maximum scores

Countries

Egypt

Contacts

Primary Contacthany f Sallam, md
hany.farouk@aswu.edu.eg+20102435461
Backup Contactnahla w Shady, md
hanygyne@yahoo.com+201022336052

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026